D. M. Grennan
University of Manchester
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by D. M. Grennan.
Annals of the Rheumatic Diseases | 1994
E. J. Davies; Rachelle Donn; M. C. Hillarby; D. M. Grennan; W. Ollier
OBJECTIVES--To determine whether the TAP2 transporter gene, which lies between HLA-DP and HLA-DQ, is involved in determining susceptibility to systemic lupus erythematosus (SLE). METHODS--TAP2 types were determined by ARMS-PCR in 89 white patients with SLE and 156 control subjects. RESULTS--No particular TAP2 dimorphism or allele was associated with SLE or with any clinical/immunological subgroup of SLE. Furthermore, there was no evidence for significant linkage disequilibrium between TAP2 and HLA-DQ/DR in SLE. CONCLUSIONS--These data suggest that TAP2 is not a disease susceptibility gene for SLE and that the disease-predisposing haplotypes do not extend as far as TAP2. This indicates that any HLA-DP association with SLE must be independent of other class II (DQ/DR) associations.
Annals of the Rheumatic Diseases | 1994
E. J. Davies; C. J. Hutchings; M. C. Hillarby; R. P. Donn; Robert G. Cooper; Elaine M. Hay; Robert M. Bernstein; P. J. L. Holt; D. M. Grennan; William Ollier
OBJECTIVES--To determine whether HLA-DP genes are involved in determining susceptibility to systemic lupus erythematosus (SLE). METHODS--HLA-DPA1 and DPB1 genes were amplified by PCR of DNA samples from a panel of patients with SLE and normal controls. Amplified DNA was blotted on to nylon filters and probed with sequence-specific oligonucleotide (SSO) probes. RESULTS--No DPA1 or DPB1 allele was significantly associated with SLE, or with any immunological or clinical subset of SLE. Evidence was found for only limited linkage disequilibrium between HLA-DP and HLA-DQ/DR variants, and none between HLA-DP and the TAP2 gene. CONCLUSIONS--These data indicate that HLA-DP genes do not contribute towards determining susceptibility to SLE.
Rheumatology | 1993
M. C. Hillarby; M. J. Mcmahon; D. M. Grennan; Robert G. Cooper; R. W. E. Clarkson; E. J. Davies; P. A. Sanders; C. Chatitopadhyay; D. Swinson
Rheumatology | 1995
E. J. Davies; G. Steers; W. Ollier; D. M. Grennan; Robert G. Cooper; Elaine M. Hay; M. C. Hillarby
Rheumatology | 1993
E. J. Davies; M. C. Hillarby; Robert G. Cooper; Elaine M. Hay; J. R. Green; S. Shah; R. M. Bernstein; P. J. L. Holt; D. M. Grennan
Rheumatology | 1993
M. J. Mcmahon; M. C. Hillarby; R. W. E. Clarkson; Sally Hollis; D. M. Grennan
Rheumatology | 1992
R. W. E. Clarkson; P. A. Sanders; D. M. Grennan
Rheumatology | 1982
D. M. Grennan; Lesley Caygill
Rheumatology | 1991
D. Sidebottom; D. M. Grennan; J. R. Green; P. A. Sanders; W. Ollier; G. De Langeh
Rheumatology | 1993
M. C. Hillarby; W. E. R. Ollier; M. Davis; J. Davidson; P. A. Sanders; D. M. Grennan